Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at http://www.ucl.ac.uk/finance/research/post_award/post_award_contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Expression and localization of NUB1 in Tauopathy and Alzheimer’s disease models
  • Publication Type:
  • Authors:
    Guarascio R, Edwards F, Salih D, van der Spuy J
  • Publication date:
  • Name of conference:
    2015 UCL Neuroscience symposium
  • Conference place:
    London, UK
  • Conference start date:
  • Conference finish date:
Alzheimer’s disease (AD) is characterized at a subcellular level by intracellular neurofibrillary tangles (NFTs), aggregates of hyperphosphorylated Tau, and by senile plaques, extracellular aggregates of amyloid beta peptides. Previous data revealed that Nedd8 ultimate buster 1 (NUB1) plays a role in reducing the aggregation and phosphorylation of Tau in an in vitro model. To clarify the role of NUB1 in AD, the spatiotemporal expression and localization of NUB1 was analyzed in T301L, a mouse model for Tauopathy characterized by NFTs, and in TASTPM mice, characterized by early development of senile plaques. The analysis revealed no change in the level of NUB1 expression in T301L mice and a significant decrease at 12 months in TASTPM mice. In brain cryosections, NUB1 expression was detected in the hippocampus and entorhinal cortex. Subcellularly, NUB1 was localized predominantly in the neuronal nuclei, but also in neuronal processes. In both mouse models at 12 months, NUB1 signal was observed to co-localize with AT8 positive cytoplasmic aggregates. Moreover in TASTPM mice, a NUB1 cytoplasmic signal was observed in non-neuronal cells. Our data confirm that NUB1 could be a therapeutic target in AD and also help to establish the appropriate window of opportunity for therapeutic intervention.
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Researchers
Institute of Ophthalmology
Neurodegenerative Diseases
Institute of Ophthalmology
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by